全文获取类型
收费全文 | 2847篇 |
免费 | 193篇 |
国内免费 | 109篇 |
专业分类
儿科学 | 25篇 |
妇产科学 | 4篇 |
基础医学 | 155篇 |
临床医学 | 334篇 |
内科学 | 654篇 |
皮肤病学 | 1篇 |
神经病学 | 37篇 |
特种医学 | 83篇 |
外国民族医学 | 2篇 |
外科学 | 636篇 |
综合类 | 536篇 |
预防医学 | 49篇 |
眼科学 | 1篇 |
药学 | 156篇 |
3篇 | |
中国医学 | 149篇 |
肿瘤学 | 324篇 |
出版年
2024年 | 3篇 |
2023年 | 31篇 |
2022年 | 58篇 |
2021年 | 100篇 |
2020年 | 98篇 |
2019年 | 86篇 |
2018年 | 70篇 |
2017年 | 72篇 |
2016年 | 101篇 |
2015年 | 97篇 |
2014年 | 160篇 |
2013年 | 143篇 |
2012年 | 141篇 |
2011年 | 169篇 |
2010年 | 140篇 |
2009年 | 139篇 |
2008年 | 118篇 |
2007年 | 125篇 |
2006年 | 131篇 |
2005年 | 142篇 |
2004年 | 127篇 |
2003年 | 117篇 |
2002年 | 100篇 |
2001年 | 84篇 |
2000年 | 87篇 |
1999年 | 68篇 |
1998年 | 45篇 |
1997年 | 47篇 |
1996年 | 53篇 |
1995年 | 53篇 |
1994年 | 45篇 |
1993年 | 34篇 |
1992年 | 27篇 |
1991年 | 19篇 |
1990年 | 24篇 |
1989年 | 12篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1974年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有3149条查询结果,搜索用时 15 毫秒
991.
胆胃康治胆汁返流性胃炎合并胆系疾病的研究 总被引:2,自引:0,他引:2
应用胆胃康治疗胆汁返流性胃炎合并胆囊炎、胆石症45例,与吗丁啉、熊去氧胆酸对照,并进行实验研究,观察中药对人工胆酸胃液三羟胆酸、PH值、总酸度的影响。结果表明,胆胃康能明显缓解、消除临床症状,改善幽门功能抑制返流,治疗胃粘膜炎症病变,并有明显消炎利胆排石作用,临床总有效率93.3%,胃粘膜炎症好转率66.7%,明显优于西药。实验结果提示,该中药尚有降低三羟胆酸浓度,增加胃内酸度的作用 相似文献
992.
目的 :探讨胆囊癌组织中nm2 3 H1和p16基因蛋白表达的意义。方法 :应用免疫组织化学方法检测 4 2例胆囊癌组织中nm2 3 H1和p16蛋白的表达 ,并与良性胆囊组织作对比研究。结果 :4 2例胆囊癌组织中nm2 3 H1和p16蛋白的阳性表达率分别为 4 0 5 %、4 7 6 % ,均明显低于胆囊良性组织 ,且其表达水平与肿瘤的临床病理分期、转移及预后有密切关系。结论 :检测nm2 3 H1和p16蛋白表达水平可以作为判断胆囊癌转移和预后的指标。 相似文献
993.
994.
Matsuhashi N Satake S Yawata K Asakawa E Mizoguchi T Kanematsu M Kondo H Yasuda I Nonaka K Tanaka C Misao A Ogura S 《World journal of gastroenterology : WJG》2006,12(28):4599-4601
A 54-year-old woman was admitted to our hospital with the complaint of right upper quadrant pain. Upon physical examination the vital signs of the patient were within normal ranges. Ultrasonography and computed tomography (CT) examination of the abdomen was obtained, which demonstrated a large dilatated cystic structure, measuring approximately 68.6 mm x 48.6 mm, with marked distension and inflammation. Additionally, the enhanced CT was characterized by the non-enhanced wall of the gallbladder. As the third examination in this study, magnetic resonance imaging (MRI), namely coronal MRI and magnetic resonance cholangio-pancreatography (MRCP), were performed. The MRCP demonstrated a dilatation of the gallbladder but detected no neck of the gallbladder. Simple cholecystectomy was performed. Macroscopic findings included a distended and gangrenous gallbladder, and closer examination revealed a counterclockwise torsion of 360 degrees on the gallbladder mesentery. Coronal MRI and MRCP showing characteristic radiography may be useful in making a definitive diagnosis. 相似文献
995.
Oe A Kawabe J Torii K Kawamura E Higashiyama S Kotani J Hayashi T Kurooka H Tsumoto C Kubo S Shiomi S 《Annals of nuclear medicine》2006,20(10):699-703
OBJECTIVE: Because thickening of the gallbladder wall is observed not only in patients with gallbladder cancer but also in those with benign diseases such as chronic cholecystitis and gallbladder adenomyosis, it is difficult to distinguish between benign and malignant gallbladder wall thickening by conventional techniques of diagnostic imaging such as computed tomography (CT), magnetic resonance imaging (MRI), and abdominal ultrasonography (US). In the present study, we attempted to distinguish between benign and malignant gallbladder wall thickening by means of fluorine-18-fluorodeoxyglucose (FDG)-Positron emission tomography (PET). METHODS: FDG-PET was performed in 12 patients with gallbladder wall thickening detected by CT or US, to determine whether it was benign or malignant. Emission scans were taken, beginning 45 minutes after intravenous administration of FDG, and SUV was calculated as an indicator of glucose metabolism. RESULTS: Of the 12 patients, 4 showed positive uptake of FDG in the gallbladder wall. Of these 4 patients, 3 had gallbladder cancer. The remaining one, who had chronic cholecystitis, had false-positive findings. The other 8 patients had negative uptake of FDG in the gallbladder wall. Two of these 8 underwent surgical resection, which yielded a diagnosis of chronic cholecystitis. The other 6 patients exhibited no sign of gallbladder malignancy and have been followed without active treatment. CONCLUSIONS: FDG-PET appears able to distinguish between benign and malignant gallbladder wall thickening. 相似文献
996.
Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas 总被引:1,自引:0,他引:1
Molecular markers for cancers are not only useful for cancer detection and prognostic prediction, but may also serve as potential therapeutic targets. In order to identify reliable molecular markers for prognostic prediction in gallbladder carcinoma (GBC), we evaluated the immunohistochemical expression of 15 proteins, namely p53, p27, p16, RB, Smad4, PTEN, FHIT, GSTP1, MGMT, E-cadherin, nm23, CD44, TIMP3, S100A4, and promyelocytic leukemia (PML) in 138 cases of GBC using the tissue microarray method. The prognostic significance was analyzed for each protein. Overexpression of p53 and S100A4, and loss of p27, p16, RB, Smad4, FHIT, E-cadherin and PML expression were associated with poor survival. In particular, PML and p53 showed considerable potential as independent prognostic markers. Patients with normal PML and p53 expression displayed favorable outcomes, compared to those showing abnormal expression of either or both proteins (49% vs. 23% in a 5-year survival rate; 60 months vs. 11 months in median survival, respectively; P=0.009). Thus, PML and p53 are potential candidates for development as clinically applicable molecular prognostic markers of GBC, and may be effective therapeutic targets for the disease in the future. 相似文献
997.
We performed a meta-analysis of studies of the association between excess body weight and risk of gallbladder cancer identified from MEDLINE and EMBASE databases from 1966 to February 2007 and the references of retrieved articles. A random-effects model was used to combine results from eight cohort studies and three case-control studies, with a total of 3288 cases. Compared with individuals of 'normal weight', the summary relative risk of gallbladder cancer for those who were overweight or obese was 1.15 (95% CI, 1.01-1.30) and 1.66 (95% CI, 1.47-1.88) respectively. The association with obesity was stronger for women (relative risk, 1.88; 95% CI, 1.66-2.13) than for men (relative risk, 1.35; 95% CI, 1.09-1.68). There was no statistically significant heterogeneity among the results of individual studies. This meta-analysis confirms the association between excess body weight and risk of gallbladder cancer. 相似文献
998.
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials 总被引:8,自引:0,他引:8
Owing to the lack of randomised controlled trials no standard of chemotherapy exists in the treatment of advanced biliary tract carcinoma. 5-fluorouracil or gemcitabine is recommended based on small and predominately phase II trials. The aim of this analysis was to analyse existing trials, even small and nonrandomised, and identify superior regimens. Chemotherapy trials published in English from 1985 to July 2006 were analysed as well as ASCO abstracts from 1999 to 2006. Response rate (RR=CR+PR), tumour control rate (TCR=CR+PR+SD), time to tumour progression (TTP), overall survival (OS), and toxicity were analysed. One hundred and four trials comprising 112 trial arms and 2810 patients, thereof 634 responders and 1368 patients with tumour control were analysed. Pooled RR and TCR were 22.6 and 57.3%, respectively. Significant correlations of RR and TCR with survival times were found. Subgroup analysis showed superior RRs for gallbladder carcinoma (GBC) compared with cholangiocarcinoma, but shorter OS for GBC. Furthermore, superior RRs and TCRs of gemcitabine and platinum containing regimens were found with highest RRs and TCRs in the combination subgroup. Based on published results of predominately phase II trials, gemcitabine combined with platinum compounds represents the provisional standard of chemotherapy in advanced biliary tract cancer, unless a new evidence-based standard has been defined. 相似文献
999.
Jiao X Huang J Wu S Lv M Hu Y Jianfu Su X Luo C Ce B 《International journal of cancer. Journal international du cancer》2007,121(3):501-505
The human oxoguanine glycosylase 1(hOGG1) gene encodes a DNA glycosylase that is involved in excision repair of 8-OH-dG (8-hydroxy-2-deoxyguanine) from oxidatively-damaged DNA. To determine whether hOGG1 plays a role in the risk for adenocarcinoma of the gallbladder, we tested the association of this polymorphism with gallbladder cancer in a Chinese population-based, case control study of 204 cases and 209 controls. The subjects were genotyped with a polymerase chain reaction-restriction fragment length polymorphism (PCR-RELP) assay. The association between the genetic polymorphism of this gene and risk of the cancer was examined by using a multivariate analysis. We found that the distribution of hOGG1 Ser326Cys genotypes among controls (Ser/Ser, 37.3%; Ser/Cys, 53.6% and Cys/Cys, 9.1%) was significantly different from that among gallbladder cancer cases (Ser/Ser, 43.1%; Ser/Cys, 36.3% and Cys/Cys, 20.6%). Significantly increased risk for gallbladder cancer was both the hOGG1 326Ser/Cys (Odds ratio [OR] = 1.9, 95% confidence interval (CI) = 1.0-3.7) and hOGG1 326Cys/Cys genotypes (OR = 4.5, 95% CI = 1.1-22.4). We observed no statistically significant association between hOGG1 genotype and gallbladder cancer association in gallstone absence. In contrast, a near-significant increase in risk for gallbladder cancer was observed for gallstone presence with the hOGG1 326Ser/Cys genotype (OR = 2.2, CI = 1.4-3.5) whereas a significant increase in association for gallbladder cancer was observed for gallstone presence with the 326Cys/Cys genotype (OR = 6.1, CI = 2.1-27.2). These data corresponded with the fact that a significant trend towards increased association for gallbladder cancer was observed with potentially higher-risk hOGG1 genotypes in gallstone presence(p < 0.001, chi(2) trend test)but not in gallstone absence(p = 0.89, chi(2) trend test). A significant increase in risk for gallbladder cancer was observed for larger gallstone (those with stone diameters 2 cm or greater) with the hOGG1 326Ser/Cys(OR = 1.9, 95% CI = 1.1-2.9) and hOGG1 326Cys/Cys genotypes(OR = 5.9, 95% CI = 1.6-18.0). These data are consistent with the observation that a significant trend towards increased risk for gallbladder cancer was observed with potentially higher-risk hOGG1 genotypes in gallbladder cancer patients with larger gallstone (p < 0.001, chi(2) trend test). However, we observed no statistically significant association between hOGG1 genotype and gallbladder cancer risk in gallbladder cancer patients with smaller gallstone (those with stone diameters 2 cm smaller) (hOGG1 326Ser/Cys:OR = 2.2, 95% CI = 0.8-4.0; hOGG1 326Cys/Cys:OR = 2.9, 95% CI = 0.6-29.4; p = 0.06, chi(2) tread test). These results suggest that hOGG1 Ser326Cys polymorphism is associated with gallbladder cancer risk. 相似文献
1000.
Gallbladder cancer in India: a dismal picture 总被引:1,自引:0,他引:1
Batra Y Pal S Dutta U Desai P Garg PK Makharia G Ahuja V Pande GK Sahni P Chattopadhyay TK Tandon RK 《Journal of gastroenterology and hepatology》2005,20(2):309-314
BACKGROUND: Gallbladder cancer (GBC) is one of the most common gastrointestinal malignancies. The data regarding GBC are, however, limited. METHODS: Records of 634 patients with GBC over a 10-year period were examined with regard to the clinical presentation, investigative findings, treatment, operative findings and outcome. RESULTS: The mean age of patients was 51 +/- 11 years and men : women ratio was 0.36:1.00. Pain, jaundice and hepatomegaly were seen in 81.0%, 76.0% and 61.5% patients, respectively. On imaging, a mass replacing the gallbladder was seen in 73% patients. Gallstones were present in 54% patients. Surgery was carried out in 291 (46%) patients and endoscopic treatment in 72 (19%) patients but no intervention was carried out in the remaining patients because of disseminated disease. Among the patients who were operated on, 2.0% had stage I GBC, 3.4% stage II, 17.5% stage III, 47.0% stage IVa and 29.8% stage IVb. Radical resection was possible in 133 (46%) patients. The 30-day mortality was 10% with most (90%) deaths in patients with stage IV disease. The median survival after simple cholecystectomy and radical surgery was 33.5 and 12.0 months, respectively. However, among those who underwent debulking, palliative bypass or exploratory laparotomy alone, the survival ranged between 1 and 3 months. Logistic regression analysis showed that only radical resection improved the long-term survival (P < 0.05). CONCLUSIONS: The majority of patients with GBC in India have advanced unresectable disease. Detection of GBC at an early stage is incidental and rare but is associated with long-term survival. Radical surgery, when feasible, is the only option for achieving long-term survival. 相似文献